Pregnancy Multivitamin: Affected lot exceeds the acceptable intake limit for N-nitroso-folic acid
Brand(s)
Last updated
Summary
Product
Pregnancy Multivitamin
Issue
Health products - Product safety
What to do
Consult your health care professional if you have any health concerns.
Distribution
Alberta
British Columbia
Ontario
Quebec
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
JAMP Pharma |
Pregnancy Multivitamin |
DIN 02535718 |
Tablet |
Blue tablets only: Folic acid 1.1 mg / Vitamin B12 12 mcg / Vitamin D3 600 IU / Calcium 300 mg |
LKE08 |
Issue
Affected lot exceeds the acceptable intake limit for N-nitroso-folic acid
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
JAMP Pharma Corporation.
1310 Nobel, Boucherville, QC, J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Alberta
British Columbia
Ontario
Quebec
Recall class
Type II
Identification number
RA-76338
Get notified
Receive notifications for new and updated recalls and alerts by category.